SCHEMBL6880137

SCHEMBL6880137

NC(=O)c1c[nH]c(=O)nc1N[C@@H]1O[C@H](CO)C[C@H]1O

nearest known ligand 0.33

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 6/20 0.33
MAPK9 P45984 3/20 0.31
ADORA3 P0DMS8 1/20 0.31
MAPK10 P53779 1/20 0.31
BTK Q06187 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6886820 0.84 MEN1 (0.38)
SCHEMBL6887745 0.84 LMNA (0.31)
SCHEMBL7029787 0.84 LMNA (0.31)
SCHEMBL6888686 0.83 TK1 (0.31)
SCHEMBL6884998 0.83 GSK3B (0.34)
SCHEMBL6880576 0.83
SCHEMBL6879994 0.82 GSK3B (0.31)
SCHEMBL6880956 0.81
SCHEMBL6885469 0.80 GSK3B (0.30)
SCHEMBL6885730 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1411954-A2 MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION Pharmasset Limited (BB) 2004-04-28 EP disclosed
WO-2002032920-A2 MODIFIED NUCLEOSIDES FOR TREATMENT OF VIRAL INFECTIONS AND ABNORMAL CELLULAR PROLIFERATION PHARMASSET LIMITED (BB) 2002-04-25 WO disclosed